Albemarle Corporation logo
ALBAlbemarle Corporation

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
3.259B3.259B4.008B4.555B4.505B4.107B3.842B4.670B5.226B
1.090B1.090B1.618B1.932B1.807B1.519B1.192B1.665B1.830B
Short-Term Investments
0.000.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
1.090B1.090B1.618B1.932B1.807B1.519B1.192B1.665B1.830B
659.482M659.482M764.773M841.178M879.738M807.855M1.066B1.018B1.198B
1.347B1.347B1.179B1.533B1.641B1.656B1.503B1.658B1.800B
15.140B15.140B16.374B17.148B17.292B16.999B16.610B17.455B18.388B
8.525B8.525B8.729B9.222B9.253B9.303B9.450B9.258B9.837B
1.488B1.488B1.500B1.491B1.671B1.606B1.583B1.638B1.601B
Intangible Assets
207.617M207.617M214.233M229.949M234.948M229.739M230.753M246.078M243.335M
Long-Term Investments
1.023B1.023B900.926M914.040M890.384M1.125B1.118B1.180B1.161B
Total Current Liabilities
1.576B1.576B1.798B2.004B1.950B1.944B1.966B1.911B1.958B
933.781M933.781M913.529M903.171M858.781M917.954M943.887M1.223B1.323B
74.628M74.628M74.077M445.384M444.911M410.477M398.023M3.012M3.213M
Total Liabilities
5.031B5.031B6.593B6.879B6.793B6.725B6.410B6.965B6.905B
1.807B1.807B3.119B3.181B3.178B3.129B3.118B3.566B3.520B
1.882B1.882B3.297B3.735B3.718B3.640B3.616B3.569B3.523B
Net Debt (Cash)
792.022M792.022M1.679B1.803B1.911B2.122B2.423B1.904B1.692B
9.850B9.850B9.533B9.996B10.241B10.028B9.962B10.241B11.223B
Common Stock
1.179M1.179M1.178M1.177M1.177M1.177M1.176M1.176M1.175M
4.843B4.843B4.614B5.117B5.367B5.434B5.482B5.496B6.654B
2.072.072.232.272.312.111.952.442.67
0.190.190.350.370.360.360.360.350.31

Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
4.008B3.842B5.217B5.187B1.994B2.206B2.225B1.998B
1.618B1.192B889.900M1.499B439.272M746.724M613.110M555.320M
Short-Term Investments
0.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
1.618B1.192B889.900M1.499B439.272M746.724M613.110M555.320M
764.773M1.066B1.835B1.449B700.058M530.838M752.448M697.887M
1.179B1.503B2.161B2.076B798.620M750.237M768.984M700.540M
16.374B16.610B18.271B15.457B10.974B10.451B9.861B7.582B
8.729B9.450B9.633B7.091B6.064B5.355B5.043B3.021B
1.500B1.583B1.630B1.618B1.598B1.666B1.579B1.567B
Intangible Assets
214.233M230.753M261.858M287.870M308.947M349.105M354.622M386.143M
Long-Term Investments
900.926M1.118B1.370B1.151B912.008M656.244M579.813M528.722M
Total Current Liabilities
1.798B1.966B3.560B2.741B1.874B1.802B1.409B1.183B
913.529M943.887M2.088B2.052B647.986M483.221M574.138M522.516M
74.077M398.023M625.761M2.128M389.920M804.677M187.336M307.294M
Total Liabilities
6.593B6.410B8.606B7.266B5.169B5.982B5.767B3.823B
3.119B3.118B3.541B3.215B2.004B2.767B2.863B1.398B
3.297B3.616B4.280B3.316B2.521B3.689B3.188B1.705B
Net Debt (Cash)
1.679B2.423B3.391B1.817B2.082B2.942B2.575B1.150B
9.533B9.962B9.412B7.983B5.625B4.268B3.932B3.585B
Common Stock
1.178M1.176M1.174M1.172M1.170M1.069M1.061M1.056M
4.614B5.482B6.987B5.601B3.097B3.155B2.943B2.566B
2.231.951.471.891.061.221.581.69
0.350.360.450.420.450.860.810.48

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Albemarle Corporation

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Charlotte, NC
8,300 employees
Basic Materials / Chemicals - Specialty
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Jerry Kent Jr.